BioSpace News Archive

Batavia Biosciencesannounces today that the International AIDS Vaccine Initiative (IAVI) and Batavia Biosciences will work together under a grant to advance the development of a Lassa fever vaccine.

Christmas is the time for giving, and that’s exactly what the Kent-based company decided to do this year with their reverse advent calendar. A popular idea this year, the reverse advent calendar requires you to put in a gift instead of receiving one and the 2nd generation family business donated their reverse advent calendar to the homeless with the help of their Charity of the Year, Porchlight.

BC Platforms AG, a world leader in genomic data management and analytics, today announces that it has partnered with Medaffcon Oy, a company specialized in generating Real World Evidence for health-related decision-making.

Cannabis tonic crashes the party, beating out mainstream brands in two categories

On November 29, 2018, RegenLab USA, LLC filed a Notice with the United States District Court for the Southern District of New York to dismiss its patent infringement claims against all of the remaining customers of Eclipse MedCorp, LLC.

Maryland-based urgent care centers, ExpressCare Urgent Care Center announces the opening of its newest walk-in medical clinic in Manassas, Virginia. (10076 Dumfries Road, Manassas, VA)

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced financial results for its fiscal 2018 fourth quarter and year ended September 30, 2018.

Welltower Inc. (NYSE: WELL), a leading provider of health care infrastructure, today announced that it has joined a global group of over 2,000 business organizations taking a leadership stance on gender equality by signing the UN Women’s Empowerment Principles.

Welltower Inc. (NYSE: WELL) joins a growing coalition of organizations pledging to advance diversity and inclusion in the workplac

Glaukos Corporation (NYSE: GKOS), announced today that a single-site international study of glaucoma subjects recently published in Ophthalmology and Therapy showed that the iStent inject® Trabecular Micro-Bypass System, combined with cataract surgery, achieved a 37% reduction in mean intraocular pressure (IOP) to 14.3 mmHg after three years of follow-up.